RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity (Q28300038)

2

0 references

Zhiyong Hao

3

0 references

Wenjing Li

4

0 references

Yan Kong

5

0 references

Lianxian Cui

6

0 references

Chi Ma

7

0 references

Denian Ba

8

0 references

Wei He

Journal of Biological Chemistry

9

0 references

language of work or name

English

0 references

publication date

29 June 2007

0 references

published in

0 references

volume

282

0 references

issue

26

0 references

page(s)

18922-8

0 references

cites work

Roles of the NKG2D immunoreceptor and its ligands

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

NKG2D is a costimulatory receptor for human naive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Activation of V gamma 9V delta 2 T cells by NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

NKG2D ligation without T cell receptor engagement triggers both cytotoxicity and cytokine production in dendritic epidermal T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

21 January 2018

UL16 binding proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

ULBP4 is a novel ligand for human NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Proteolytic release of soluble UL16-binding protein 2 from tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Soluble MICA in malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Human Cytomegalovirus-Encoded UL16 Discriminates MIC Molecules by Their 2 Domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702504200